Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guidelines for the management of chronic hepatitis C in patients infected after substance use.
Robaeys G, Buntinx F, Bottieau E, Bourgeois S, Brenard R, Colle I, De Bie J, Matheï C, Mulkay JP, Van Damme P, Van Ranst M, Verrando R, Michielsen P, Bourgeois N, Brenard R, de Galocsy Ch, Delwaide J, Henrion J, Horsmans Y, Michielsen P, Reynaert H, Robaeys G, Sprengers D; Steering Committee of the Belgian Association for the Study of the Liver (BASL). Robaeys G, et al. Among authors: horsmans y. Acta Gastroenterol Belg. 2005 Jan-Mar;68(1):38-45. Acta Gastroenterol Belg. 2005. PMID: 15832586 Review. No abstract available.
Hepatitis C: screening, treatment and prevention practical guidelines.
Michielsen P, Brenard R, Bourgeois N, De Galocsy Ch, Delwaide J, Henrion J, Horsmans Y, Nevens F, Reynaert H, Robaeys G, Sprengers D, Van Vlierberghe H; Steering Committee Belgian Association for the Study of the Liver. Michielsen P, et al. Among authors: horsmans y. Acta Gastroenterol Belg. 2003 Jan-Mar;66(1):15-9. Acta Gastroenterol Belg. 2003. PMID: 12812144 No abstract available.
Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust study.
Van Vlierberghe H, Adler M, Bastens B, Colle I, Delwaide J, Henrion J, Horsmans Y, Michielsen P, Golstein P, Mulkay JP, Van Steenbergen W, Yap P, Nevens F, Denys AM, Brasseur JP. Van Vlierberghe H, et al. Among authors: horsmans y. Acta Gastroenterol Belg. 2010 Jan-Mar;73(1):5-11. Acta Gastroenterol Belg. 2010. PMID: 20458844 Free article.
Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial.
Van Vlierberghe H, Leroux-Roels G, Adler M, Bourgeois N, Nevens F, Horsmans Y, Brouwer J, Colle I, Delwaide J, Brenard R, Bastens B, Henrion J, de Vries RA, de Galocsy C, Michielsen P, Robaeys G, Bruckers L. Van Vlierberghe H, et al. Among authors: horsmans y. J Viral Hepat. 2003 Nov;10(6):460-6. doi: 10.1046/j.1365-2893.2003.00466.x. J Viral Hepat. 2003. PMID: 14633181 Clinical Trial.
Weekly pegylated interferon alpha-2b vs daily interferon a-2b versus standard regimen of interferon a-2b in the treatment of patients with chronic hepatitis C virus infection.
Horsmans Y, Colle I, Van Vlierberghe H, Langlet P, Adler M, Bourgeois N, Brenard R, Michielsen P, Goossens A, Bruckers L; Belgian Assocation for the Study of the Liver. Horsmans Y, et al. Acta Gastroenterol Belg. 2008 Jul-Sep;71(3):293-7. Acta Gastroenterol Belg. 2008. PMID: 19198574 Clinical Trial.
Characteristics, treatment, and virologic responses of chronic hepatitis C patients treated with peginterferon alfa-2a and ribavirin in belgium: a sub-analysis of the PROPHESYS study.
Mulkay JP, Bourgeois S, Lasser L, De Galocsy C, Tomasovic S, Horsmans Y, Van Vlierberghe H; Belgian PROPHESYS investigators. Mulkay JP, et al. Among authors: horsmans y. Acta Gastroenterol Belg. 2014 Mar;77(1):30-40. Acta Gastroenterol Belg. 2014. PMID: 24761689 Free article.
Hepatitis C virus (HCV) prevalence estimation in the adult general population in Belgium : a meta-analysis.
Muyldermans G, Bielen R, Botterman R, Bourgeois S, Colle I, Deressa B, Devolder G, Horsmans Y, Hutse V, Lanthier N, Lasser L, Platteau S, Robaeys G, Suin V, Verhelst X, Van Vlierberghe H, Van Baelen L. Muyldermans G, et al. Among authors: horsmans y. Acta Gastroenterol Belg. 2019 Oct-Dec;82(4):479-485. Acta Gastroenterol Belg. 2019. PMID: 31950802 Free article.
Clinical trial: a randomized trial of pegylated-interferon-alpha-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients.
Langlet P, D'Heygere F, Henrion J, Adler M, Delwaide J, Van Vlierberghe H, Mulkay JP, Lasser L, Brenard R, Horsmans Y, Michielsen P, Laureys A, Nevens F. Langlet P, et al. Among authors: horsmans y. Aliment Pharmacol Ther. 2009 Aug 15;30(4):352-63. doi: 10.1111/j.1365-2036.2009.04052.x. Epub 2009 May 26. Aliment Pharmacol Ther. 2009. PMID: 19485978 Free article. Clinical Trial.
335 results